The US FDA's EMDAC is set to hold a meeting to assess the benefit-risk profile o...
Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financin...
Affecting more than 162,000 patients worldwide, global clinical trials are resea...
The EC has approved Celltrion’s Omlyclo, an omalizumab biosimilar for reference ...
Biocon has entered an exclusive licence and supply agreement with Handok to comm...
In this issue: Lula's progress plan for Brazil, tracking opioid lawsuit settleme...
The clinical-stage biotech will share preliminary safety and efficacy data with ...
AstraZeneca has the option to acquire SixPeaks in the next two years if the latt...
Rhythm expects Imcivree will be available on the NHS in England and Wales within...
As the nitrosamine scandal continues, we explore the advancements in parenteral ...
When new medicines hit the market, sharing educational content with physicians, ...
Genmab has concluded the acquisition of ProfoundBio, a clinical-stage biotechnol...
Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the ...
AltruBio has secured $225m in an oversubscribed Series B financing round to prop...
Evotec will close an Austrian facility as it shuts down its gene therapy busines...
Download our list of leading pharmaceutical process automation technologies to m...